These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 9741671

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Virus inactivation in blood components by photoactive phenothiazine dyes.
    Wagner SJ.
    Transfus Med Rev; 2002 Jan; 16(1):61-6. PubMed ID: 11788930
    [Abstract] [Full Text] [Related]

  • 3. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.
    Trannoy LL, Terpstra FG, de Korte D, Lagerberg JW, Verhoeven AJ, Brand A, van Engelenburg FA.
    Vox Sang; 2006 Aug; 91(2):111-8. PubMed ID: 16907871
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA.
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [Abstract] [Full Text] [Related]

  • 6. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J, de Sousa G.
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The application of photosensitisers to tropical pathogens in the blood supply.
    Wainwright M, Baptista MS.
    Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):240-8. PubMed ID: 21864797
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dithiaporphyrin derivatives as photosensitizers in membranes and cells.
    Minnes R, Weitman H, You Y, Detty MR, Ehrenberg B.
    J Phys Chem B; 2008 Mar 13; 112(10):3268-76. PubMed ID: 18278897
    [Abstract] [Full Text] [Related]

  • 12. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
    Corash L.
    Baillieres Best Pract Res Clin Haematol; 2000 Dec 13; 13(4):549-63. PubMed ID: 11102276
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K, Lin L, Eichler H, Mayaudon V, Flament J, Klüter H.
    Vox Sang; 2004 May 13; 86(4):239-45. PubMed ID: 15144528
    [Abstract] [Full Text] [Related]

  • 15. In vitro demonstration of the heavy-atom effect for photodynamic therapy.
    Gorman A, Killoran J, O'Shea C, Kenna T, Gallagher WM, O'Shea DF.
    J Am Chem Soc; 2004 Sep 01; 126(34):10619-31. PubMed ID: 15327320
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathogen inactivation: a new paradigm for blood safety.
    McCullough J.
    Transfusion; 2007 Dec 01; 47(12):2180-4. PubMed ID: 18036073
    [No Abstract] [Full Text] [Related]

  • 18. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.
    Roback JD, Conlan M, Drew WL, Ljungman P, Nichols WG, Preiksaitis JK.
    Transfus Med Rev; 2006 Jan 01; 20(1):45-56. PubMed ID: 16373187
    [Abstract] [Full Text] [Related]

  • 19. Pathogen reduction of blood components.
    Solheim BG.
    Transfus Apher Sci; 2008 Aug 01; 39(1):75-82. PubMed ID: 18602343
    [Abstract] [Full Text] [Related]

  • 20. Quality of methylene-blue-treated fresh-frozen plasma stored up to 27 months.
    Moog R, Reichenberg S, Hoburg A, Müller N.
    Transfusion; 2010 Feb 01; 50(2):516-8. PubMed ID: 20233360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.